A phase II study of clinical activity of SCH 717454 (robatumumab) in patients with relapsed osteosarcoma and Ewing sarcoma

  1. Anderson, P.M.
  2. Bielack, S.S.
  3. Gorlick, R.G.
  4. Skubitz, K.
  5. Daw, N.C.
  6. Herzog, C.E.
  7. Monge, O.R.
  8. Lassaletta, A.
  9. Boldrini, E.
  10. Pápai, Z.
  11. Rubino, J.
  12. Pathiraja, K.
  13. Hille, D.A.
  14. Ayers, M.
  15. Yao, S.-L.
  16. Nebozhyn, M.
  17. Lu, B.
  18. Mauro, D.
Revue:
Pediatric Blood and Cancer

ISSN: 1545-5017,  1545-5009

Année de publication: 2016

Volumen: 63

Número: 10

Pages: 1761-1770

Type: Article

DOI: 10.1002/PBC.26087 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus